Black chickpeas, or 'kala chana', have various health benefits for the whole body. Studies have confirmed that black chickpeas have a rich nutritional profile that can nourish the body with essential ...

Live concerts, fireworks and roaring stadium crowds can reach dangerously high volumes — loud enough to cause permanent hearing loss. But what was the loudest sound ever recorded on Earth? The answer ...

Investing.com -- Kala Pharmaceuticals Inc (NASDAQ:KALA) stock dropped 6.7% Friday after the company announced the closing of its previously announced registered direct offering that raised ...

ARLINGTON, Mass., Dec. 05, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA) (“KALA” or the “Company”), today announced the closing of its previously announced registered direct offering priced at ...

KALA BIO, Inc. (NASDAQ: KALA) shares jumped 22.16% to $1.13 in after-hours trading on Wednesday. Check out the current price of KALA stock here. Securities and Exchange Commission filings indicate ...

Kala Bio focuses on developing therapies for rare and severe diseases of the eye using its proprietary mesenchymal stem cell secretome platform. Its lead product candidate, KPI-012, had previously ...

ARLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative ...

Hyderabad: President Droupadi Murmu will inaugurate the Bharatiya Kala Mahotsav 2025 at Rashtrapati Nilayam here on Friday. According to an official release, Chief Minister A Revanth Reddy will ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Arlington biotech has been ...

Kala Bio said it laid off most of its employees after receiving notice that its lender, Oxford Finance, intends to foreclose on all of its remaining assets. The move follows the biotech company's ...

Sept 29 (Reuters) - Kala Bio (KALA.O), opens new tab will stop developing its experimental treatment for a type of eye condition after it failed to meet the main goal in a mid-stage study, sending the ...